Logistics Manager & SC Opex at Bristol-Myers Squibb

Shanghai, China

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Ability to work onsite (site-essential or site-by-design with at least 50% onsite presence, as determined by role nature)
Capability to physically travel to visit customers, patients, or business partners and attend meetings as directed (for field-based or remote-by-design roles)
Full Covid-19 vaccination and up-to-date boosters strongly recommended

Responsibilities

(None explicitly listed in the provided job description.)

Skills

Key technologies and capabilities for this role

Logistics ManagementSupply ChainOpexProduction OptimizationOperations Management

Questions & Answers

Common questions about this position

What is the salary for the Logistics Manager & SC Opex role?

This information is not specified in the job description.

Is this Logistics Manager position remote or onsite?

This information is not specified in the job description.

What skills are required for this Logistics Manager role?

This information is not specified in the job description.

What is the company culture like at Bristol Myers Squibb?

BMS offers a supportive culture promoting global participation in clinical trials, with shared values of passion, innovation, urgency, accountability, inclusion, and integrity that bring out the highest potential of colleagues. The work environment emphasizes balance, flexibility, challenging and meaningful work, and high-achieving teams.

What tips do you have for applying to this role at BMS?

If the role intrigues you but doesn’t perfectly match your resume, BMS encourages you to apply anyway, as you could be one step away from transformative work.

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free